Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate-Reference-Cited by-同舟云学术

Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate

Published:2016-08-22 Issue:11 Volume:32 Page:1873-1881
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Joshi Kruti¹,Pan Xiaoyun²,Wang Rosa²,Yang Erru²,Benson Carmela¹

Affiliation:

1. Janssen Scientific Affairs LLC, Titusville, NJ, USA;

2. Evidera, Lexington, MA, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2016.1219706

Reference47 articles.

1. National Institute of Mental Health. Schizophrenia. National Institute of Mental Health Web site, 2014. Available at: http://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml [Last accessed 27 July 2016]

2. The Economic Burden of Schizophrenia in the United States in 2002

3. Cost of Schizophrenia in the Medicare Program

4. The cost of relapse and the predictors of relapse in the treatment of schizophrenia

5. Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of the COVID-19 pandemic on the trend of prescribing long-acting injections of paliperidone and risperidone in Central Serbia;Frontiers in Psychiatry;2023-12-21

2. Comparison of health resource usage and costs associated with first-generation and second-generation long-acting injectable antipsychotics for patients with schizophrenia: A nationwide population-based cohort study;Asian Journal of Psychiatry;2023-11

3. The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia;Neuropsychiatric Disease and Treatment;2023-03

4. Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan;Schizophrenia Research;2023-02

5. Mental healthcare utilisation by patients before and after receiving paliperidone palmitate treatment: mirror image analyses;BMJ Open;2022-04